Literature DB >> 14610169

Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection.

Kitai Kim1, Peggy A Garner-Hamrick, Chris Fisher, Denis Lee, Paul F Lambert.   

Abstract

The biological activities of the papillomavirus E2 protein in transcription, replication, and maintenance of the papillomavirus genome rely on the E2 protein's ability to bind that genome specifically. The E2 binding sites (E2BSs), located within the long control region (LCR) of human papillomavirus (HPV) genomes, contain potential sites for 5'methylation at cytosine (CpG) residues. The E2 protein's capacity to bind E2BS in vitro is inhibited by methylation of these cytosines (59). Herein, we describe experiments to assess the influence of methylation on E2 function in cells. E2's ability to activate transcription was inhibited by the global methylation of CpG dinucleotides in E2-responsive transcriptional templates or when only the CpG dinucleotides within the E2BSs of a transcriptional template were methylated. Thus at least one biological activity of E2 that is dependent on its ability to bind DNA in a site-specific manner is influenced by the methylation status of its cognate binding site. The activity of DNA methylases is influenced by the differentiation status of mammalian cells. The life cycle of HPVs is tied to the differentiation of its host cells within stratified squamous epithelia. To investigate whether methylation of the papillomavirus genomes is influenced by the differentiation status of host epithelial cells, we analyzed HPV16 DNA harvested from a cervical epithelial cell line that was isolated from an HPV16-infected patient. We found, using bisulfite treatment to discriminate between methylated and unmethylated cytosines, that the HPV16 LCR was selectively hypomethylated in highly differentiated cell populations. In contrast, the HPV16 LCR from poorly differentiated, basal cell-like cells contained multiple methylated cytosines and were often methylated at E2BSs, particularly E2BS(2). These experiments indicate that the methylation state of the viral genome, and particular that of E2BSs, may vary during the viral life cycle, providing a novel means for modulating E2 function. These studies also uncovered an extensive pattern of methylation at non-CpG dinucleotides indicative of de novo methylation. The potential implications of this de novo methylation pattern are discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14610169      PMCID: PMC262585          DOI: 10.1128/jvi.77.23.12450-12459.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  69 in total

1.  Bovine papillomavirus type 1 E1 and simian virus 40 large T antigen share regions of sequence similarity required for multiple functions.

Authors:  K C Mansky; A Batiza; P F Lambert
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

2.  Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription.

Authors:  P L Jones; G J Veenstra; P A Wade; D Vermaak; S U Kass; N Landsberger; J Strouboulis; A P Wolffe
Journal:  Nat Genet       Date:  1998-06       Impact factor: 38.330

3.  Cell-type-specific separate regulation of the E6 and E7 promoters of human papillomavirus type 6a by the viral transcription factor E2.

Authors:  B Rapp; A Pawellek; F Kraetzer; M Schaefer; C May; K Purdie; K Grassmann; T Iftner
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

4.  Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1.

Authors:  L S Chuang; H I Ian; T W Koh; H H Ng; G Xu; B F Li
Journal:  Science       Date:  1997-09-26       Impact factor: 47.728

5.  Different mechanisms contribute to the E2-mediated transcriptional repression of human papillomavirus type 18 viral oncogenes.

Authors:  C Demeret; C Desaintes; M Yaniv; F Thierry
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

6.  Inhibition of DNA methyltransferase and induction of Friend erythroleukemia cell differentiation by 5-azacytidine and 5-aza-2'-deoxycytidine.

Authors:  F Creusot; G Acs; J K Christman
Journal:  J Biol Chem       Date:  1982-02-25       Impact factor: 5.157

7.  Retrovirus genomes methylated by mammalian but not bacterial methylase are non-infectious.

Authors:  D Simon; H Stuhlmann; D Jähner; H Wagner; E Werner; R Jaenisch
Journal:  Nature       Date:  1983 Jul 21-27       Impact factor: 49.962

8.  A transcriptional repressor encoded by BPV-1 shares a common carboxy-terminal domain with the E2 transactivator.

Authors:  P F Lambert; B A Spalholz; P M Howley
Journal:  Cell       Date:  1987-07-03       Impact factor: 41.582

9.  E2 polypeptides encoded by bovine papillomavirus type 1 form dimers through the common carboxyl-terminal domain: transactivation is mediated by the conserved amino-terminal domain.

Authors:  A A McBride; J C Byrne; P M Howley
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

10.  Differential requirements for conserved E2 binding sites in the life cycle of oncogenic human papillomavirus type 31.

Authors:  F Stubenrauch; H B Lim; L A Laimins
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

View more
  62 in total

Review 1.  Papillomavirus genome structure, expression, and post-transcriptional regulation.

Authors:  Zhi-Ming Zheng; Carl C Baker
Journal:  Front Biosci       Date:  2006-09-01

Review 2.  Replication and partitioning of papillomavirus genomes.

Authors:  Alison A McBride
Journal:  Adv Virus Res       Date:  2008       Impact factor: 9.937

3.  Epigenetics of human papillomaviruses.

Authors:  Eric Johannsen; Paul F Lambert
Journal:  Virology       Date:  2013-08-13       Impact factor: 3.616

4.  High-throughput detection of human papillomavirus-18 L1 gene methylation, a candidate biomarker for the progression of cervical neoplasia.

Authors:  Tolga Turan; Mina Kalantari; Kate Cuschieri; Heather A Cubie; Hanne Skomedal; Hans-Ulrich Bernard
Journal:  Virology       Date:  2006-12-18       Impact factor: 3.616

Review 5.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

Review 6.  HPV epigenetic mechanisms related to Oropharyngeal and Cervix cancers.

Authors:  Marina Di Domenico; Giancarlo Giovane; Soumaya Kouidhi; Rosamaria Iorio; Maurizio Romano; Francesco De Francesco; Antonia Feola; Camilla Siciliano; Luigi Califano; Antonio Giordano
Journal:  Cancer Biol Ther       Date:  2018-05-14       Impact factor: 4.742

7.  Lack of methylation in the upstream region of human papillomavirus type 6 from aerodigestive tract papillomas.

Authors:  Agustín Enrique Ure; Ola Forslund
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

8.  Distinct human papillomavirus type 16 methylomes in cervical cells at different stages of premalignancy.

Authors:  Janet L Brandsma; Ying Sun; Paul M Lizardi; David P Tuck; Daniel Zelterman; G Kenneth Haines; Maritza Martel; Malini Harigopal; Kevin Schofield; Matthew Neapolitano
Journal:  Virology       Date:  2009-05-13       Impact factor: 3.616

Review 9.  Human papillomavirus infections: warts or cancer?

Authors:  Louise T Chow; Thomas R Broker
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

10.  Methylation of human papillomavirus Type 16 CpG sites at E2-binding site 1 (E2BS1), E2BS2, and the Sp1-binding site in cervical cancer samples as determined by high-resolution melting analysis-PCR.

Authors:  Elise Jacquin; Alice Baraquin; Rajeev Ramanah; Xavier Carcopino; Adrien Morel; Séverine Valmary-Degano; Ignacio G Bravo; Silvia de Sanjosé; Didier Riethmuller; Christiane Mougin; Jean-Luc Prétet
Journal:  J Clin Microbiol       Date:  2013-07-17       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.